Day: March 23, 2022

Sixth Consecutive Quarter of Record Growth Doubled Augmentation and Reconstruction Market Share Since 2019 Broadened Market Opportunity with Addition of Novel, FDA-Cleared Fat Grafting Technology SANTA BARBARA, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results for the fourth quarter and full year ended December 31, 2021. Q4 and Full Year 2021 Financial HighlightsNet sales of $22.6 million, representing growth of 26.6% over the fourth quarter of 2020, excluding discontinued operations. Net sales of $80.7 million, representing growth of 47% over the full year 2020, excluding discontinued operations. Cash of $51.8 million as of December 31, 2021.Business...

Launched Commercial Service for First Responders with FirstNet by AT&T and Signed Milestone Agreement with a Nationwide Carrier for E911 Ended Year with a Strong Balance Sheet Including No Debt and $100 Million in Cash Signed Important Platform Agreements in Full Year 2021, Resulting in $2.4 Million in Customer Billings MCLEAN, Va., March 23, 2022 (GLOBE NEWSWIRE) — NextNav Inc. (NASDAQ: NN) (“NextNav” or the “Company”), a leader in next generation GPS and 3D geolocation, today reported financial results for NextNav’s fourth quarter and full year ended December 31, 2021. Ganesh Pattabiraman, NextNav Co-founder and CEO, stated, “It was an exciting year for NextNav, capped off by the completion of our business combination with Spartacus Acquisition Corp., and continued execution against our strategic growth initiatives. We signed...

AUSTIN, Texas, March 23, 2022 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or “the Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, today announced preliminary financial results for the year ended December 31, 2021. “The past year was an incredibly pivotal period for Phunware, as we made significant progress across all key segments of our business,” said Alan S. Knitowski, President, CEO and Co-Founder of Phunware. “The combination of our direct and indirect go-to-market strategies came to fruition in conjunction with the re-opening of the post-pandemic economy, resulting in extremely promising opportunities for our core MaaS business. Additionally, the acquisition of Lyte Technology late last year not only materially added...

WORCESTER, Mass., March 23, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the full year ended December 31, 2021. Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, “In 2021, we continued to make great strides in advancing our cell and gene therapy programs. Notably, the U.S. Food and Drug Administration (“FDA”) approved two Mustang Investigational New Drug (“IND”) applications, the first to initiate a pivotal multicenter Phase 2 clinical trial to evaluate MB-107, a lentiviral gene therapy for the treatment...

~ Company Exceeds EPS Expectations ~ ~ Initiates Fiscal 2022 Guidance ~ HARRISBURG, Pa., March 23, 2022 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today reported financial results for the fourth quarter and full-year fiscal 2021. Fourth Quarter Summary:     Total net sales decreased 2.8% to $501.1 million.   Comparable store sales decreased 10.5% from the prior year increase of 8.8%. Comparable store sales decreased 2.0% compared with the fourth quarter of fiscal 2019. The Company opened five new stores, ending the quarter with 431 stores in 29 states, a year-over-year increase in store count of 11.1%. Operating income decreased 32.2% to $57.5 million. Adjusted operating income(1) decreased 32.1% to $57.3 million and adjusted operating margin(1) decreased 500 basis points to 11.4%. Net...

IRVINE, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the quarter and year ended December 31, 2021 and provided a business update. 2021 HighlightsRaised gross proceeds of $94 million in an initial public offering (IPO); cash runway sufficient to fund planned operations into 2024 Fast Track Designation granted in the U.S. for REN001 in primary mitochondrial myopathy (PMM) Initiated enrollment of STRIDE, a global, double-blind, randomized, placebo-controlled Phase 2b clinical trial of REN001 in patients with PMM Initiated STRIDE AHEAD, an open-label extension safety trial of REN001 in patients with...

GUILFORD, Conn., March 23, 2022 (GLOBE NEWSWIRE) — Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™, today announced fourth quarter and full year 2021 financial results and provided a business update. “2021 was an incredible year at Hyperfine. We accelerated our Swoop launch by installing 23 commercial systems and over 50 total systems*, secured an experienced management team and Board of Directors, raised over $160 million in gross proceeds from our business combination, transitioned to a public company, and created several new opportunities for research at top clinical institutions while expanding our sales presence around the globe,” said Dave Scott, Chief Executive Officer and President of Hyperfine. “We look forward to continued...

— Record Earnings Driven by Excellent Execution and Continued Strength in Direct to Consumer — — Fiscal 2022 Earnings Per Share Projected to Range from $8.75 to $9.15 — — Increases Quarterly Dividend 31% to $0.55 per Share — ATLANTA, March 23, 2022 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE:OXM) today announced financial results for its fourth quarter and full fiscal year 2021 ended January 29, 2022. Due to the material impact of COVID-19 on the Company’s business in fiscal 2020, this release includes comparisons of fiscal 2021 results to both fiscal 2020 and fiscal 2019. Full fiscal 2021 consolidated net sales increased to $1.142 billion compared to $749 million in fiscal 2020 and $1.123 billion in fiscal 2019. Sales of Lanier Apparel, which the Company exited in the third quarter of fiscal...

Fourth quarter results:Orders grew 27% and revenue increased 11% compared to prior year, with broad-based growth across all segments Significant inflationary pressures and supply chain disruptions continued to impact operating resultsOutlook:First quarter guidance reflects significant revenue growth over prior year and continuation of supply chain disruptions and inflationary pressures Company targets strong revenue and earnings growth in fiscal 2023 driven by expected benefits of pricing actions and anticipated stronger demand from companies transforming their offices to support hybrid and in-person workGRAND RAPIDS, Mich., March 23, 2022 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) today reported fourth quarter revenue of $753.1 million and a net loss of $2.2 million, or $0.02 per share. In the prior year, Steelcase...